1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsParker Bridge Fellow Awards is sponsored by Parker Institute for Cancer Immunotherapy. Parker Bridge Fellow Awards is a grant from the Parker Institute for Cancer Immunotherapy that funds early-career researchers working to advance cancer immunotherapy science.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Early Career Researcher Awards - Parker Institute for Cancer Immunotherapy You are using an outdated browser. Please upgrade your browser to improve your experience.
Research Institutions Our academic collaborators’ seminal contributions push the field forward Directory Our constellation of renowned thinkers and partners Strategic Partnerships The right collaborators across pharma, biotech and nonprofit Early Career Researcher Awards The next generation of scientific leaders in cancer immunotherapy The Latest Stories & Announcements News Coverage PICI in the News Podcast From Bench to Fireside Mission & Vision Develop breakthrough immune therapies to turn all cancers into curable diseases faster Leadership & Team The driving force behind PICI’s research and operations Careers Join us.
Change lives. Early Career Researcher Awards Investing in Next Generation Talent We have an ambitious mission. Not only do we invest in the talent of today, we train the cancer immunotherapy leaders of tomorrow.
Our financial support, access to cutting-edge technology, impressive network of scientists, and resources empower the next generation of leaders. With PICI, these early career researchers can take bold questions and big ideas and turn them into research that has the potential to transform immunotherapy treatments. Early Career Researcher Awards Since our inception, we’ve been planning for the future.
And the brightest young investigators in cancer immunotherapy are the future. In 2016, we launched the Parker Scholars, Parker Bridge Fellows and Parker Senior Fellows to support the most ambitious early career researchers. Risk-taking is required.
New thinking is mandatory. We challenge them to explore their boldest ideas to propel the field forward. We equip them with cutting-edge tools and technologies.
We give them access to data from clinical trials and pre-published papers. We connect them with leading researchers and their peers in cancer immunotherapy. We do our part so they can focus on advancing their science.
The end goal: a future where we don’t have to fear cancer.
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators Announcement, Our Impact, Press Release Developing Next-Gen Scientific Leaders Announcement, Our Impact, Press Release Funding the Future of Cancer Research Cancer Research Heroes, Our Impact The Power and Promise of High-Risk Science The Parker Institute for Cancer Immunotherapy Trains the Next Generation of Scientific Leaders in Cancer Immunotherapy Cancer Research Heroes, Our Impact, Press Release The Parker Institute for Cancer Immunotherapy Expands its Network to Include More Rising Stars in Cancer Immunotherapy Guest Post: PICI Catalyzes Scientific Innovation Funding the Future of Cancer Research
According to the current listing, eligibility includes: Early-career researchers in cancer immunotherapy; specific eligibility criteria not detailed on the overview page. Confirm the full requirements in the official notice before applying.
The current listing shows $220,000 over 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Parker Bridge Fellow Awards is funded by Parker Institute for Cancer Immunotherapy. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article